Wed, February 3, 2016
Tue, February 2, 2016
Mon, February 1, 2016
Fri, January 29, 2016
Thu, January 28, 2016
Wed, January 27, 2016
Tue, January 26, 2016
Mon, January 25, 2016
Fri, January 22, 2016
Thu, January 21, 2016
Wed, January 20, 2016
Tue, January 19, 2016
Fri, January 15, 2016
Thu, January 14, 2016
Wed, January 13, 2016
Tue, January 12, 2016
Mon, January 11, 2016
Sun, January 10, 2016
Fri, January 8, 2016
Thu, January 7, 2016
Wed, January 6, 2016
Tue, January 5, 2016
Mon, January 4, 2016

Alethia Young Initiated (AGIO) at Buy and Held Target at $75 on, Jan 20th, 2016


//stocks-investing.news-articles.net/content/201 .. -buy-and-held-target-at-75-on-jan-20th-2016.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation



Alethia Young of Credit Suisse, Initiated "Agios Pharmaceuticals, Inc." (AGIO) at Buy and Held Target at $75 on, Jan 20th, 2016.

Alethia has made no other calls on AGIO in the last 4 months.



There are 2 other peers that have a rating on AGIO. Out of the 2 peers that are also analyzing AGIO, all agree with Alethia's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Michael Schmidt of "Leerink Swann" Downgraded from Buy to Hold on, Monday, December 7th, 2015
  • John Newman of "Canaccord Genuity" Maintained at Hold with Decreased Target to $70 on, Monday, October 19th, 2015

Publication Contributing Sources